Botox and Dermal Fillers

Botox and hyaluronic acid dermal fillers at Regenevéda are administered by the clinic's medical team at the Loop location for wrinkle reduction, facial volume restoration, and contouring. Botox (botulinum toxin type A) targets dynamic wrinkles driven by repetitive facial muscle movement, with effects lasting up to six months. Hyaluronic acid fillers address static volume loss in areas such as cheeks, nasolabial folds, lips, and perioral lines. Regenevéda's integrative approach positions injectables within a broader longevity and skin health programme rather than as isolated cosmetic procedures.

Botox and Dermal Filler injections at Regenevéda are performed by medical practitioners at the clinic's 8 S Michigan Ave, Suite 812, Loop location, integrating aesthetic injectables into the clinic's overarching longevity and regenerative medicine programme. Botox (onabotulinum toxin A, marketed as Botox Cosmetic by AbbVie/Allergan) works by competitively blocking acetylcholine release at the neuromuscular junction, temporarily reducing the contraction of the targeted facial muscles that drive dynamic wrinkle formation. Common treatment areas include glabellar lines (between the brows), forehead horizontal lines, lateral canthal lines (crow's feet), and brow lifting. The relaxation effect typically becomes apparent within three to five days, peaks at two weeks, and lasts four to six months before the nerve terminal regenerates functional acetylcholine release capacity. Dosing is measured in units, with aesthetic doses calibrated to preserve natural facial expressiveness while reducing the muscle-driven folding that deepens wrinkles over time with repeated movement. Hyaluronic acid (HA) dermal fillers — a class that includes commercially available products such as Juvederm and Restylane — work through a different mechanism: direct volumetric restoration via injection of a cross-linked HA gel into the subcutaneous and sub-dermal tissue planes. HA is a naturally occurring polysaccharide present in the dermis that binds water (up to 1,000 times its own weight) and contributes to tissue volume and turgor; cross-linking the HA polymer chains with BDDE chemistry confers structural longevity, with duration of effect ranging from six to eighteen months depending on the product density, injection depth, and anatomical site. At Regenevéda, fillers are used to address age-related midface volume loss, deepen nasolabial folds, restore lip volume and vermillion border definition, and contour the jawline. The clinic's practitioners document that filler effects may last up to six months, though HA fillers in low-mobility sites typically persist longer. The integrative context of Dr. Thom Lobe's practice means injectables are offered alongside skin quality programmes (laser, PRP, chemical peels) and internal longevity protocols rather than as a standalone cosmetic service.